Clinical Trial Update: Study of Metformin With Simvastatin for Men With Prostate Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating metformin with simvastatin for prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• metformin (metformin)

Snippet

Sponsor: Nicholas Mitsiades | Conditions: Prostate Carcinoma | Phase 2 | Status: WITHDRAWN